Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma

Area of Science:

• Gynecologic Oncology
• Molecular Oncology
• Translational Research

Background:

• The human placenta exhibits tumor-like characteristics, including growth, invasion, and immune evasion.
• Mechanisms driving placental disease progression from hydatidiform moles to choriocarcinoma remain unclear.
• Aggressiveness differences in choriocarcinoma based on origin (moles vs. term delivery) are not well understood.

Purpose of the Study:

• To compare transcriptomic profiles of complete moles, postmolar choriocarcinoma, and post-term delivery choriocarcinoma.
• To identify molecular pathways involved in the transition from premalignant to malignant placental disease.
• To investigate potential differences in choriocarcinoma aggressiveness based on origin.

Main Methods:

• Transcriptomic profiling using a 730-gene panel covering 13 cancer-associated pathways.
• Differential gene expression analysis between complete moles and postmolar choriocarcinoma.
• Differential gene expression analysis between postmolar and post-term delivery choriocarcinoma.

Main Results:

• Thirty-three differentially expressed genes were identified between complete moles and postmolar choriocarcinoma, indicating transforming growth factor-beta (TGF-β) pathway dysregulation.
• SALL4, an upstream regulator of TGF-β, showed significantly higher expression in postmolar choriocarcinoma compared to moles.
• No significant gene expression differences were found between postmolar and post-term delivery choriocarcinoma samples.

Conclusions:

• The TGF-β pathway plays a critical role in the progression of placental malignancies.
• SALL4 expression is a potential marker for choriocarcinoma development.
• TGF-β family members warrant further investigation as biomarkers and therapeutic targets for placental cancers.